FINWIRES · TerminalLIVE
FINWIRES

加拿大皇家银行表示，大型银行第一季度在资本市场表现强劲。

-- 加拿大皇家银行资本市场（RBC Capital Markets）周四在一份发给客户的报告中指出，受咨询和股票交易业务强劲增长的推动，美国主要银行第一季度资本市场收入超出预期。 据该券商称，摩根大通（JPM）、美国银行（BAC）、花旗集团（C）、高盛（GS）和摩根士丹利（MS）的资本市场总收入同比增长近20%。 RBC表示，其中高盛的咨询收入增长最为显著，达到68%。投资银行服务费总额较上年同期增长31%，主要得益于股票资本市场的增长。 RBC全球金融研究联席主管杰拉德·卡西迪（Gerard Cassidy）在报告中表示：“咨询收入的增长主要归功于2025年宣布的大型交易在（2026年第一季度）完成，而股票资本市场收入则受益于后续发行和可转换债券发行的增加。” 股票交易上涨约26%，其中花旗集团表现最为强劲，摩根大通涨幅最小。 卡西迪表示，五家银行的固定收益、外汇和大宗商品业务总收入增长了10%。除高盛外，其余五家银行的固定收益、外汇和大宗商品业务均实现了同比增长。 据该券商称，考虑到宏观经济和地缘政治的不确定性，各家银行对近期投资银行业务持“谨慎乐观”态度。 美伊之间为期两周的停火协议即将到期。白宫对与德黑兰达成协议持乐观态度，并指出第二轮谈判可能在巴基斯坦举行。此前在伊斯兰堡举行的和平谈判已于上周末结束，但未能达成协议。 卡西迪表示：“许多投资银行指出，（第一季度）积压订单充足，我们认为在市场波动性较小的环境下，这些订单可以变现。” “然而，经济不确定性和市场波动性持续的时间越长，这些公司就越难增加其投资银行业务的收入。”

Price: $309.39, Change: $+3.46, Percent Change: +1.13%

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB